M. Marynowski

Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy

J. Fichna, H. Zatorski, M. Marynowski, 2016, Pharmacological reports : PR.

Role of environmental pollution in irritable bowel syndrome.

J. Fichna, H. Zatorski, M. Marynowski, 2015, World journal of gastroenterology.

Role of Platelet-Derived Growth Factor (PDGF) in Asthma as an Immunoregulatory Factor Mediating Airway Remodeling and Possible Pharmacological Target

P. Kuna, G. Kardas, M. Panek, 2020, Frontiers in Pharmacology.

Salvinorin A analogues PR‐37 and PR‐38 attenuate compound 48/80‐induced itch responses in mice

B. Roth, J. Fichna, J. Do Régo, 2015, British journal of pharmacology.

2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of action.

R. Earl, C. Teleha, S. Tam, 1998, Journal of medicinal chemistry.

2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of action.

R. Earl, C. Teleha, S. Tam, 1998, Journal of medicinal chemistry.

New insights into the regulation of TGF‐β/Smad and MPK signaling pathway gene expressions by nasal allergen and methacholine challenge test in asthma

P. Kuna, M. Karbownik, M. Panek, 2021, Clinical and translational allergy.